| 注册
首页|期刊导航|肿瘤药学|240例土家族及汉族肿瘤患者药品不良反应情况比较

240例土家族及汉族肿瘤患者药品不良反应情况比较

王银辉 张芳 吴玉娇 杨艳玲

肿瘤药学2018,Vol.8Issue(6):979-982,4.
肿瘤药学2018,Vol.8Issue(6):979-982,4.DOI:10.3969/j.issn.2095-1264.2018.06.33

240例土家族及汉族肿瘤患者药品不良反应情况比较

Analysis of Adverse Drug Reactions of 240 Cases of Tujia and Han Cancer Patients

王银辉 1张芳 1吴玉娇 1杨艳玲1

作者信息

  • 1. 恩施土家族苗族自治州中心医院临床药学科,湖北 恩施,445000
  • 折叠

摘要

Abstract

Objective To explore the characteristics of adverse drug reactions (ADR) in Tujia and Han cancer patients in this region. Methods The adverse reactions of antitumor drugs and related adjunctive drugs in 240 cases of Tujia and Han cancer patients were retro-spectively analyzed. Results There were no differences in age, sex distribution and severity of ADR among Tujia and Han cancer patients (P>0.05). Antitumor drugs and related adjunctive drugs caused the most cases of ADR in both Tujia and Han group of patients. The most common types of ADR included skin and appendage lesions, gastrointestinal system damage. There were differences in ADR between the patients with different categories of primary tumors (P<0.05). Conclusion There were differences in tumor types of Tujia and Han patients with ADR and doctors should pay attention to it.

关键词

肿瘤患者/土家族/药品不良反应

Key words

Tumor patients/Tujia Population/Adverse drug reactions

分类

医药卫生

引用本文复制引用

王银辉,张芳,吴玉娇,杨艳玲..240例土家族及汉族肿瘤患者药品不良反应情况比较[J].肿瘤药学,2018,8(6):979-982,4.

肿瘤药学

OACSTPCD

2095-1264

访问量0
|
下载量0
段落导航相关论文